Vanguard Global Advisers
RDY icon

Vanguard Global Advisers’s Dr. Reddy's Laboratories RDY Stock Holding History

Vanguard Global Advisers’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Buy
23,245
+1,044
+5% +$14.1K ﹤0.01% 2279
2026
Q1 		$307K Buy
+22,201
New +$309K ﹤0.01% 2233

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Global Advisers's RDY Position: Q2 2026 in Review

Vanguard Global Advisers increased its Dr. Reddy's Laboratories (RDY) stake by 4.7% in Q2 2026, buying an estimated $14.1K and bringing the position to 23,245 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #2279.

Vanguard Global Advisers first reported a position in RDY in Q1 2026 and has held it in 2 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Vanguard Global Advisers held 23,245 shares of Dr. Reddy's Laboratories worth $337K as of Q2 2026.
  • Vanguard Global Advisers bought 1,044 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $14.1K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2279 holding.
  • Vanguard Global Advisers first reported a position in Dr. Reddy's Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.